Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    NIAID | Open Studies | diabetes
Show Display Options
Rank Status Study
1 Recruiting Type 1 Diabetes Extension Study
Conditions: Type 1 Diabetes;   Diabetes Mellitus
2 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
3 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
4 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
5 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
6 Recruiting Sustainable East Africa Research in Community Health
Conditions: HIV;   Tuberculosis;   Hypertension;   Diabetes;   Maternal Child Health;   Cost Effectiveness
Interventions: Other: Universal ART in a streamlined care model;   Other: Annual Community Health Campaigns;   Other: Targeted PrEP, Targeted testing, and Targeted care interventions;   Other: Baseline community-based HIV and multi-disease testing

Indicates status has not been verified in more than two years